PTPRD gene associated with blood pressure response to atenolol and resistant hypertension

被引:37
作者
Gong, Yan [1 ,2 ]
McDonough, Caitrin W. [1 ,2 ]
Beitelshees, Amber L. [3 ,4 ]
El Rouby, Nihal [1 ,2 ]
Hiltunen, Timo P. [5 ,6 ]
O'Connell, Jeffrey R. [3 ,4 ]
Padmanabhan, Sandosh [7 ]
Langaee, Taimour Y. [1 ,2 ]
Hall, Karen
Schmidt, Siegfried O. F. [8 ]
Curry, Robert W., Jr. [8 ]
Gums, John G. [1 ,2 ,8 ]
Donner, Kati M. [9 ]
Kontula, Kimmo K. [5 ,6 ]
Bailey, Kent R. [10 ]
Boerwinkle, Eric [11 ]
Takahashi, Atsushi [12 ]
Tanaka, Toshihiro [12 ]
Kubo, Michiaki [12 ]
Chapman, Arlene B. [13 ]
Turner, Stephen T. [10 ]
Pepine, Carl J. [14 ]
Cooper-DeHoff, Rhonda M. [1 ,2 ,14 ]
Johnson, Julie A. [1 ,2 ,14 ]
机构
[1] Univ Florida, Dept Pharmacotherapy & Translat Res, Gainesville, FL 32610 USA
[2] Univ Florida, Ctr Pharmacogen, Gainesville, FL 32610 USA
[3] Univ Maryland, Dept Med, Baltimore, MD 21201 USA
[4] Univ Maryland, Program Personalized & Genom Med, Baltimore, MD 21201 USA
[5] Univ Helsinki, Dept Med, Helsinki, Finland
[6] Univ Cent Hosp Helsinki, Helsinki, Finland
[7] Univ Glasgow, Coll Med Vet & Life Sci, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, Glasgow, Lanark, Scotland
[8] Univ Florida, Coll Med, Dept Community Hlth & Family Med, Gainesville, FL 32610 USA
[9] Univ Helsinki, Inst Mol Med Finland, Helsinki, Finland
[10] Mayo Clin, Coll Med, Rochester, MN USA
[11] Univ Texas Houston, Ctr Human Genet, Houston, TX USA
[12] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan
[13] Emory Univ, Sch Med, Atlanta, GA USA
[14] Univ Florida, Coll Med, Div Cardiovasc Med, Gainesville, FL 32610 USA
关键词
atenolol; blood pressure response; genome-wide association study; pharmacogenomic evaluation of antihypertensive responses; pharmacogenomics; PTPRD; resistant hypertension; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; GLOBAL BURDEN; PREDICTORS; IDENTIFY;
D O I
10.1097/HJH.0000000000000714
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Objective: The aim of this study is to identify single-nucleotide polymorphisms (SNPs) influencing blood pressure (BP) response to the -blocker atenolol.Methods: Genome-wide association analysis of BP response to atenolol monotherapy was performed in 233 white participants with uncomplicated hypertension in the pharmacogenomic evaluation of antihypertensive responses study. Forty-two polymorphisms with P less than 10(-5) for association with either diastolic or systolic response to atenolol monotherapy were validated in four independent groups of hypertensive individuals (total n=2114).Results: In whites, two polymorphisms near the gene PTPRD (rs12346562 and rs1104514) were associated with DBP response to atenolol (P=3.2x10(-6) and P=5.9x10(-6), respectively) with directionally opposite association for response to hydrochlorothiazide in another group of 228 whites (P=0.0018 and P=0.00012). A different polymorphism (rs10739150) near PTPRD was associated with response to atenolol in 150 black hypertensive individuals (P=8.25x10(-6)). rs12346562 had a similar trend in association with response to bisoprolol (a different -blocker) in 207 Finnish men in the genetics of drug responsiveness in essential hypertension study. In addition, an intronic single-nucleotide polymorphism (rs4742610) in the PTPRD gene was associated with resistant hypertension in whites and Hispanics in the international verapamil SR trandolapril study (meta-analysis P=3.2x10(-5)).Conclusion: PTPRD was identified as a novel locus potentially associated with BP response to atenolol and resistant hypertension in multiple ethnic groups.
引用
收藏
页码:2278 / 2285
页数:8
相关论文
共 25 条
[1]  
[Anonymous], 2013, TOP 200 DRUGS 2012
[2]  
[Anonymous], US MED US REV 2011
[3]  
[Anonymous], 2014, CIRCULATION, DOI DOI 10.1161/01.cir.0000441139.02102.80
[4]   Genome-wide association and meta-analysis in populations from Starr County, Texas, and Mexico City identify type 2 diabetes susceptibility loci and enrichment for expression quantitative trait loci in top signals [J].
Below, J. E. ;
Gamazon, E. R. ;
Morrison, J. V. ;
Konkashbaev, A. ;
Pluzhnikov, A. ;
McKeigue, P. M. ;
Parra, E. J. ;
Elbein, S. C. ;
Hallman, D. M. ;
Nicolae, D. L. ;
Bell, G. I. ;
Cruz, M. ;
Cox, N. J. ;
Hanis, C. L. .
DIABETOLOGIA, 2011, 54 (08) :2047-2055
[5]   INDIVIDUAL-RESPONSES TO CONVERTING ENZYME-INHIBITORS AND CALCIUM-ANTAGONISTS [J].
BIDIVILLE, J ;
NUSSBERGER, J ;
WAEBER, G ;
PORCHET, M ;
WAEBER, B ;
BRUNNER, HR .
HYPERTENSION, 1988, 11 (02) :166-173
[6]   Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].
Calhoun, David A. ;
Jones, Daniel ;
Textor, Stephen ;
Goff, David C. ;
Murphy, Timothy P. ;
Toto, Robert D. ;
White, Anthony ;
Cushman, William C. ;
White, William ;
Sica, Domenic ;
Ferdinand, Keith ;
Giles, Thomas D. ;
Falkner, Bonita ;
Carey, Robert M. .
HYPERTENSION, 2008, 51 (06) :1403-1419
[7]   Genome-Wide Association Study of Anthropometric Traits and Evidence of Interactions With Age and Study Year in Filipino Women [J].
Croteau-Chonka, Damien C. ;
Marvelle, Amanda F. ;
Lange, Ethan M. ;
Lee, Nanette R. ;
Adair, Linda S. ;
Lange, Leslie A. ;
Mohlke, Karen L. .
OBESITY, 2011, 19 (05) :1019-1027
[8]   COMPARISON OF PROPRANOLOL OR HYDROCHLOROTHIAZIDE ALONE FOR TREATMENT OF HYPERTENSION .3. EVALUATION OF THE RENIN-ANGIOTENSIN SYSTEM [J].
FREIS, ED ;
MATERSON, BJ ;
FLAMENBAUM, W .
AMERICAN JOURNAL OF MEDICINE, 1983, 74 (06) :1029-1041
[9]   Predictors of antihypertensive drug responses:: Initial data from a placebo-controlled, randomized, cross-over study with four antihypertensive drugs (The GENRES Study) [J].
Hiltunen, Tirno P. ;
Suonsyrja, Tirno ;
Hannila-Handelberg, Tuula ;
Paavonen, Kristian J. ;
Miettinen, Helena E. ;
Strandberg, Timo ;
Tikkanen, Ilkka ;
Tilvis, Reijo ;
Pentikainen, Pertti J. ;
Virolainen, Juha ;
Kontula, Kimmo .
AMERICAN JOURNAL OF HYPERTENSION, 2007, 20 (03) :311-318
[10]  
Hjalmarson Å, 1999, LANCET, V353, P2001